Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Brandt Flags XLM as “Most Bullish Chart” – $2 in Sight?

Brandt Flags XLM as “Most Bullish Chart” – $2 in Sight?

DailyCoinDailyCoin2025/07/18 16:00
By:DailyCoin

Stellar (XLM) delivered an impressive rally this month ahead of the broader altcoin hype, but veteran trader Peter Brandt believes XLM could be the biggest winner of this bull run.

“Potentially the most bullish chart of all belongs to $XLM,” Brandt wrote in his X post.

Sponsored

However, he stresses that two critical conditions must be met for this thesis to play out.

Potentially the most bullish chart of all belongs to $XLM
XLM MUST MUST remain above Apr low and MUST MUST close decisively above $1. Until then this chart will remain range bound pic.twitter.com/NZvKLp5SVW

— Peter Brandt (@PeterLBrandt) July 17, 2025

According to Brandt, Stellar must hold above its April low of $0.203 and secure a decisive close above $1.00. If it fails either test, XLM will remain stuck in its current trading range.

The April low represents the floor of XLM’s range‑bound action. A drop below $0.203 would shatter that support, likely triggering a deeper sell‑off and invalidating the bullish setup. 

Conversely, a firm daily close above $1.00 would flip long‑standing resistance into support and activate the bullish continuation patterns.

Stellar (XLM) Forms Higher Lows and Ascending Triangle

Brandt also notes that XLM’s chart forms an ascending triangle, one of the most reliable bullish continuation patterns. 

Brandt Flags XLM as “Most Bullish Chart” – $2 in Sight? image 0 Stellar (XLM) price is forming an ascending triangle pattern and higher lows. Source: TradingView

Since 2020, each pullback in XLM has found support at successively higher prices, while a flat ceiling has repeatedly capped rallies. 

Repeated tests of the same resistance tend to exhaust sellers, increasing the likelihood of an upside breakout once that level is finally breached.

Cup‑and‑Handle Reinforcement

Peter Brands also notes that on a longer timeframe, Stellar’s (XLM) price action forms a classic cup‑and‑handle pattern.

The “cup” is the rounded U‑shape swing from the 2021 peak down to the 2022 lows near $0.07 and back up toward $0.70, followed by the “handle,” a smaller consolidation dipping to around $0.20.

Brandt Flags XLM as “Most Bullish Chart” – $2 in Sight? image 1 Brandt Flags XLM as “Most Bullish Chart” – $2 in Sight? image 2 Stellar (XLM) price shows signs of “cup and handle” pattern formation. Source: TradingView

Once the handle’s resistance is breached, the pattern typically drives the price upward by about the cup’s depth, implying a target in the $2.00 area.

Why “Most Bullish” and Upside Potential

This convergence of two proven bullish patterns (ascending triangle and cup‑and‑handle) at the same barrier is rare. At XLM’s current $0.48 level, there is over 100% upside just to re‑test $1.00, and roughly 300–400% potential to reach the $1.90–$2.00 targets implied by both patterns.

Dig into DailyCoin’s top crypto scoops:

U.S. Passes GENIUS Act, Crypto Markets Rally

SPX6900 (SPX) Flips FLOKI, Sets Sights On $2 Moonshot

People Also Ask:

What is Stellar (XLM)?

Stellar is a blockchain-based platform designed to facilitate fast, low-cost cross-border payments using its native token, XLM.

Is Stellar the same as Ripple (XRP)?

No. Stellar and Ripple were both founded by Jed McCaleb and aim to improve cross-border payments, but they are separate projects with different target audiences—Stellar focuses more on individuals and developing markets, while Ripple targets banks and financial institutions.

What is XLM used for?

XLM is used to pay transaction fees on the Stellar network and to facilitate currency conversions between different fiat and crypto assets.

Is XLM a long-term investment?

That depends on your strategy. Some view XLM as a long-term play on global remittances and tokenized finance, while others trade it based on technical trends.

Can XLM reach $2 realistically?

Technically, yes—based on chart patterns like the ascending triangle and cup‑and‑handle. However, actual performance depends on market conditions, volume, and broader altcoin sentiment.


1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales